Cite
HARVARD Citation
Romano, A. et al. (2019). Immune off‐target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma. British journal of haematology. pp. 468-479. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Romano, A. et al. (2019). Immune off‐target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma. British journal of haematology. pp. 468-479. [Online].